Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,527,280
+$818,362 QoQ
Shares Held
9,026
+40.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#341
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $89,777,668 across 18 Diagnostics & Research names. LH ranks #12 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
40,905 | $20,508,130 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
34,084 | $17,943,180 | |
| 3 | DHR |
Danaher Corp /De/
|
69,337 | $13,207,311 | |
| 4 | TWST |
Twist Bioscience Corp
|
40,732 | $4,190,508 | |
| 5 | A |
Agilent Technologies, Inc.
|
31,106 | $4,131,809 | |
| 6 | WAT |
Waters Corp /De/
|
10,809 | $4,053,807 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
18,371 | $3,549,644 | |
| 8 | NTRA |
Natera, Inc.
|
12,749 | $3,460,716 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,527,280 | 9,026 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,708,918 | 6,405 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,239,104 | 8,925 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,648,415 | 9,226 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,321,375 | 8,843 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,797,451 | 7,723 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,176,246 | 9,490 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,903,155 | 8,516 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,863,744 | 9,158 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||